NTI
Click for more information
1.19% 8.3¢ neurotech international limited

Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial, page-2

  1. Iuvenesco
    199 Posts.
    lightbulb Created with Sketch. 62
    clock Created with Sketch.
    10/07/23
    10:53
    Post #: 68703522
    Any update on the phase II/III trials that might turn in to commercialisation? Cause that might move the SP from its slumber on the bottom of the charts.
    NTI Price at posting: 4.6¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
8.3¢ 		Change
-0.001(1.19%) 		Mkt cap ! $84.44M
Open High Low Value Volume
9.0¢ 9.3¢ 8.3¢ $353.1K 4.041M

Buyers (Bids)

No. Vol. Price($)
3 61058 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 39000 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.